Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY-NC 4.0Biomolecules & Therapeutics

Beyond Receptor-Proximal Uncoupling: EGFR-PKC Signaling and Arrestin Deubiquitination-Coupled Nuclear Trafficking in GPCR Signaling Regulation

  1. 1Department of Pharmacology, College of Pharmacy, Chonnam National University Gwangju 61186 Republic of Korea

Abstract

G protein-coupled receptors (GPCRs) constitute the largest family of cell-surface signaling proteins and major therapeutic targets. Their function is critically shaped by desensitization, the attenuation of receptor responsiveness during sustained or repeated stimulation. The canonical model, established in systems such as rhodopsin and the β₂-adrenergic receptor, emphasizes GRK-mediated receptor phosphorylation, arrestin recruitment, and steric inhibition of G-protein coupling, resulting in rapid and largely reversible receptor desensitization. Accumulating evidence, however, indicates that GPCR adaptation can extend beyond this receptor-proximal mechanism. Here, I propose a Two-Level Framework that incorporates an EGFR-dependent adaptive program following sustained activation of selected GPCRs. EGFR serves as an upstream integration hub linking two complementary pathways: a PKC-dependent proximal pathway that mediates receptor-level desensitization, and a Src-PDK1-Akt-USP33 pathway proposed to promote arrestin deubiquitination and subsequent nuclear translocation of arrestin-Gβγ complexes. This translocation may reduce membrane-associated Gβγ availability, thereby contributing to persistent attenuation of receptor signaling, while also influencing nuclear transcriptional activity. The persistent component is revealed by washout-rechallenge paradigms, in which signaling remains impaired despite apparent receptor recovery. Thus, Level II represents an additional layer of GPCR adaptation in which receptor desensitization is accompanied by longer-lasting remodeling of intracellular signaling capacity. Although derived primarily from D2-like and β2-adrenergic receptor systems, this framework may apply more broadly to GPCRs capable of transactivating EGFR or related receptor tyrosine kinases, providing a broader view of desensitization that integrates receptor-level regulation with network-level adaptation.

Related

  1. Regulation of calcium-sensing-receptor trafficking and cell-surface expression by GPCRs and RAMPs
    Tristan Bouschet, Stéphane Martin, Jeremy Henley
    Trends in Pharmacological SciencesPeer-reviewedLicence not stated41 citedMolecular biology & gene regulationHAL
  2. AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity
    Caroline Gorvin, Angela Rogers, Benoit Hastoy +9
    Cell ReportsPeer-reviewedCC BYFull text86 citedMolecular biology & gene regulationHAL
  3. Gut microbiota-bile acid-immune axis: receptor signaling, metabolic regulation, and therapeutic translation
    Ruixin He, Qiangqiang Zheng, Yi Shen
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  4. Uncoupling of the allosteric signalling network in the β₁-adrenergic receptor by a negative allosteric modulator.
    Thomas H Harman, Timothy Noel, Ali Nokhbehzaim +10
    Nature communicationsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. A single domain intrabody biases the follicle-stimulating hormone receptor subcellular trafficking
    Pauline Raynaud, Juliette Gourdon, Vinesh Jugnarain +20
    Communications BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationHAL
BibTeX
@article{kim2026beyond,
  title = {{Beyond Receptor-Proximal Uncoupling: EGFR-PKC Signaling and Arrestin Deubiquitination-Coupled Nuclear Trafficking in GPCR Signaling Regulation}},
  author = {Kyeong-Man Kim},
  journal = {Biomolecules \& Therapeutics},
  year = {2026},
  month = nov,
  doi = {10.4062/biomolther.2026.132},
  url = {https://doi.org/10.4062/biomolther.2026.132},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Beyond Receptor-Proximal Uncoupling: EGFR-PKC Signaling and Arrestin Deubiquitination-Coupled Nuclear Trafficking in GPCR Signaling Regulation
AU  - Kyeong-Man Kim
PY  - 2026
DA  - 2026/11/01
JO  - Biomolecules & Therapeutics
DO  - 10.4062/biomolther.2026.132
UR  - https://doi.org/10.4062/biomolther.2026.132
AB  - G protein-coupled receptors (GPCRs) constitute the largest family of cell-surface signaling proteins and major therapeutic targets. Their function is critically shaped by desensitization, the attenuation of receptor responsiveness during sustained or repeated stimulation. The canonical model, established in systems such as rhodopsin and the β₂-adrenergic receptor, emphasizes GRK-mediated receptor phosphorylation, arrestin recruitment, and steric inhibition of G-protein coupling, resulting in rapid and largely reversible receptor desensitization. Accumulating evidence, however, indicates that GPCR adaptation can extend beyond this receptor-proximal mechanism. Here, I propose a Two-Level Framework that incorporates an EGFR-dependent adaptive program following sustained activation of selected GPCRs. EGFR serves as an upstream integration hub linking two complementary pathways: a PKC-dependent proximal pathway that mediates receptor-level desensitization, and a Src-PDK1-Akt-USP33 pathway proposed to promote arrestin deubiquitination and subsequent nuclear translocation of arrestin-Gβγ complexes. This translocation may reduce membrane-associated Gβγ availability, thereby contributing to persistent attenuation of receptor signaling, while also influencing nuclear transcriptional activity. The persistent component is revealed by washout-rechallenge paradigms, in which signaling remains impaired despite apparent receptor recovery. Thus, Level II represents an additional layer of GPCR adaptation in which receptor desensitization is accompanied by longer-lasting remodeling of intracellular signaling capacity. Although derived primarily from D2-like and β2-adrenergic receptor systems, this framework may apply more broadly to GPCRs capable of transactivating EGFR or related receptor tyrosine kinases, providing a broader view of desensitization that integrates receptor-level regulation with network-level adaptation.
SN  - 1976-9148
SN  - 2005-4483
ER  -